Initial activation of EpCAM cleavage via cell-to-cell contact

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Denzel, Sabine ^a   Maetzel, Dorothea ^a   Mack, Brigitte ^a   Eggert, Carola ^a   Bärr, Gabriele ^a   Gires, Olivier ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; EPITHELIAL CELL ADHESION MOLECULE; CELL ADHESION MOLECULE; TUMOR ANTIGEN; TUMOR ASSOCIATED ANTIGEN GA733; TUMOR-ASSOCIATED ANTIGEN GA733;

ARTICLE; CANCER CELL; CELL COUNT; CELL DENSITY; CELL INTERACTION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; GENE ACTIVATION; GENE INDUCTION; GENE OVEREXPRESSION; GENE TRANSLOCATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN DOMAIN; SIGNAL TRANSDUCTION; CELL COMMUNICATION; CONFOCAL MICROSCOPY; METABOLISM; PHYSIOLOGY; PROTEIN TRANSPORT; TUMOR CELL LINE; WESTERN BLOTTING;

ANTIGENS, NEOPLASM; BLOTTING, WESTERN; CELL ADHESION MOLECULES; CELL COMMUNICATION; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; IMMUNOPRECIPITATION; MICROSCOPY, CONFOCAL; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

EID: 71549145616     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-402     Document Type: Article

References (39)

1. Osta WA, Chen Y, Mikhitarian K, Mitas M, Salem M, Hannun YA, Cole DJ, Gillanders WE. EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy. Cancer Res 2004, 64(16):5818-5824. 10.1158/0008-5472.CAN-04-0754, 15313925.
2. Munz M, Kieu C, Mack B, Schmitt B, Zeidler R, Gires O. The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation. Oncogene 2004, 23(34):5748-5758. 10.1038/sj.onc.1207610, 15195135.
3. Maaser K, Borlak J. A genome-wide expression analysis identifies a network of EpCAM-induced cell cycle regulators. Br J Cancer 2008, 99(10):1635-1643. 10.1038/sj.bjc.6604725, 2584962, 19002182.
4. Went P, Vasei M, Bubendorf L, Terracciano L, Tornillo L, Riede U, Kononen J, Simon R, Sauter G, Baeuerle PA. Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers. Br J Cancer 2006, 94(1):128-135. 10.1038/sj.bjc.6602924, 2361083, 16404366.
5. Riethmuller G, Holz E, Schlimok G, Schmiegel W, Raab R, Hoffken K, Gruber R, Funke I, Pichlmaier H, Hirche H. Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trial. J Clin Oncol 1998, 16(5):1788-1794.
6. Armstrong A, Eck SL. EpCAM: A new therapeutic target for an old cancer antigen. Cancer Biol Ther 2003, 2(4):320-326.
7. Spizzo G, Went P, Dirnhofer S, Obrist P, Simon R, Spichtin H, Maurer R, Metzger U, von Castelberg B, Bart R. High Ep-CAM expression is associated with poor prognosis in node-positive breast cancer. Breast Cancer Res Treat 2004, 86(3):207-213. 10.1023/B:BREA.0000036787.59816.01, 15567937.
8. Maetzel D, Denzel S, Mack B, Canis M, Went P, Benk M, Kieu C, Papior P, Baeuerle PA, Munz M. Nuclear signalling by tumour-associated antigen EpCAM. Nat Cell Biol 2009, 11(2):162-171. 10.1038/ncb1824, 19136966.
9. Carpenter G, Red Brewer M. EpCAM: Another Surface-to-Nucleus Missile. Cancer Cell 2009, 15(3):165-166. 10.1016/j.ccr.2009.02.005, 19249674.
10. Gonzalez B, Denzel S, Mack B, Conrad M, Gires O. EpCAM Is Involved in Maintenance of the Murine Embryonic Stem Cell Phenotype. Stem Cells 2009, 27(8):1782-1791. 10.1002/stem.97, 19544432.
11. Ng VY, Ang SN, Chan JX, Choo AB. Characterization of Epithelial Cell Adhesion Molecule as a Surface Marker on Undifferentiated Human Embryonic Stem Cells. Stem Cells 2009,
12. Munz M, Baeuerle PA, Gires O. The Emerging Role of EpCAM in Cancer and Stem Cell Signaling. Cancer Res 2009, 15;69(14):5627-9.
13. Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 2008, 8(10):755-768. 10.1038/nrc2499, 18784658.
14. Visvader JE, Lindeman GJ. EpCAM and solid tumour fractionation. Nat Rev Cancer 2009, 9:143-143.
15. Gires O, Klein CA, Baeuerle PA. On the abundance of EpCAM on cancer stem cells. Nat Rev Cancer 2009, 9(2):143. author reply 143, 10.1038/nrc2499-c1, 19132011.
16. Fagotto F, Gumbiner BM. Cell contact-dependent signaling. Dev Biol 1996, 180(2):445-454. 10.1006/dbio.1996.0318, 8954717.
17. Riedle S, Kiefel H, Gast D, Bondong S, Wolterink S, Gutwein P, Altevogt P. Nuclear translocation and signaling of L1-CAM in human carcinoma cells requires ADAM10 and presenilin/gamma-secretase activity. Biochem J 2009, 420(3):391-402. 10.1042/BJ20081625, 19260824.
18. Stoeck A, Gast D, Sanderson MP, Issa Y, Gutwein P, Altevogt P. L1-CAM in a membrane-bound or soluble form augments protection from apoptosis in ovarian carcinoma cells. Gynecol Oncol 2007, 104(2):461-469. 10.1016/j.ygyno.2006.08.038, 17030349.
19. Mechtersheimer S, Gutwein P, Agmon-Levin N, Stoeck A, Oleszewski M, Riedle S, Postina R, Fahrenholz F, Fogel M, Lemmon V. Ectodomain shedding of L1 adhesion molecule promotes cell migration by autocrine binding to integrins. J Cell Biol 2001, 155(4):661-673. 10.1083/jcb.200101099, 2198870, 11706054.
20. Ruf P, Gires O, Jager M, Fellinger K, Atz J, Lindhofer H. Characterisation of the new EpCAM-specific antibody HO-3: implications for trifunctional antibody immunotherapy of cancer. Br J Cancer 2007, 97(3):315-21. 10.1038/sj.bjc.6603881, 2360319, 17622246.
21. Brock R, Hamelers IH, Jovin TM. Comparison of fixation protocols for adherent cultured cells applied to a GFP fusion protein of the epidermal growth factor receptor. Cytometry 1999, 35(4):353-362. 10.1002/(SICI)1097-0320(19990401)35:4<353::AID-CYTO8>3.0.CO;2-M, 10213201.
22. Munz M, Hofmann T, Scheibe B, Gange M, Junghanns K, Zeidler R, Gires O. The carcinoma-associated antigen EpCAM induces glyoxalase 1 resulting in enhanced methylglyoxal turnover. Cancer Genomics and Proteomics 2004, 1(3):241-247.
23. Munz M, Zeidler R, Gires O. The tumor-associated antigen EpCAM up-regulates the fatty acid binding protein E-FABP. Cancer Letters 2005, 225(1):151-157. 10.1016/j.canlet.2004.11.048, 15922867.
24. Juliano RL. Signal transduction by cell adhesion receptors and the cytoskeleton: functions of integrins, cadherins, selectins, and immunoglobulin-superfamily members. Annu Rev Pharmacol Toxicol 2002, 42:283-323. 10.1146/annurev.pharmtox.42.090401.151133, 11807174.
25. Cavallaro U, Christofori G. Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer 2004, 4(2):118-132.
26. Litvinov SV, Bakker HA, Gourevitch MM, Velders MP, Warnaar SO. Evidence for a role of the epithelial glycoprotein 40 (Ep-CAM) in epithelial cell-cell adhesion. Cell Adhes Commun 1994, 2(5):417-428. 10.3109/15419069409004452, 7842256.
27. Trzpis M, Bremer E, McLaughlin PM, de Leij LF, Harmsen MC. EpCAM in morphogenesis. Front Biosci 2008, 13:5050-5055. 10.2741/3063, 18508569.
28. Trzpis M, McLaughlin PM, de Leij LM, Harmsen MC. Epithelial Cell Adhesion Molecule. More than a Carcinoma Marker and Adhesion Molecule. Am J Pathol 2007, 171(2):386-95. 10.2353/ajpath.2007.070152, 1934518, 17600130.
29. Trzpis M, McLaughlin P, van Goor H, Brinker M, van Dam G, de Leij L, Popa E, Harmsen M. Expression of EpCAM is up-regulated during regeneration of renal epithelia. J Pathol 2008, 216(2):201-8. 10.1002/path.2396, 18702175.
30. Trzpis M, Popa ER, McLaughlin PM, van Goor H, Timmer A, Bosman GW, de Leij LM, Harmsen MC. Spatial and temporal expression patterns of the epithelial cell adhesion molecule (EpCAM/EGP-2) in developing and adult kidneys. Nephron Exp Nephrol 2007, 107(4):e119-131. 10.1159/000111039, 18025791.
31. Schmelzer E, Zhang L, Bruce A, Wauthier E, Ludlow J, Yao HL, Moss N, Melhem A, McClelland R, Turner W. Human hepatic stem cells from fetal and postnatal donors. J Exp Med 2007, 204(8):1973-1987. 10.1084/jem.20061603, 2118675, 17664288.
32. Litvinov SV, van Driel W, van Rhijn CM, Bakker HA, van Krieken H, Fleuren GJ, Warnaar SO. Expression of Ep-CAM in cervical squamous epithelia correlates with an increased proliferation and the disappearance of markers for terminal differentiation. Am J Pathol 1996, 148(3):865-875. 1861708, 8774141.
33. Schon MP, Schon M, Klein CE, Blume U, Bisson S, Orfanos CE. Carcinoma-associated 38-kD membrane glycoprotein MH 99/KS 1/4 is related to proliferation and age of transformed epithelial cell lines. J Invest Dermatol 1994, 102(6):987-991. 10.1111/1523-1747.ep12384258, 8006466.
34. Kuhn S, Koch M, Nubel T, Ladwein M, Antolovic D, Klingbeil P, Hildebrand D, Moldenhauer G, Langbein L, Franke WW. A complex of EpCAM, claudin-7, CD44 variant isoforms, and tetraspanins promotes colorectal cancer progression. Mol Cancer Res 2007, 5(6):553-567. 10.1158/1541-7786.MCR-06-0384, 17579117.
35. Ehrmann M, Clausen T. Proteolysis as a regulatory mechanism. Annu Rev Genet 2004, 38:709-724. 10.1146/annurev.genet.38.072902.093416, 15568990.
36. Medina M, Dotti CG. RIPped out by presenilin-dependent gamma-secretase. Cell Signal 2003, 15(9):829-841. 10.1016/S0898-6568(03)00041-X, 12834808.
37. Zoller M. Tetraspanins: push and pull in suppressing and promoting metastasis. Nat Rev Cancer 2009, 9(1):40-55. 10.1038/nrc2543, 19078974.
38. de Boer CJ, van Krieken JH, Janssen-van Rhijn CM, Litvinov SV. Expression of Ep-CAM in normal, regenerating, metaplastic, and neoplastic liver. J Pathol 1999, 188(2):201-206. 10.1002/(SICI)1096-9896(199906)188:2<201::AID-PATH339>3.0.CO;2-8, 10398165.
39. Schmelzer E, Reid LM. EpCAM expression in normal, non-pathological tissues. Front Biosci 2008, 13:3096-3100. 10.2741/2911, 17981779.